Japan's Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer's

The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...

May 12, 2023 | Friday | News
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...

May 8, 2023 | Monday | News
Korea's Daewoong Pharma inks $477 M deal with US partner for autoimmune disease treatment

South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...

April 28, 2023 | Friday | News
New drug discovery research collaboration between Korea & UK

South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...

April 19, 2023 | Wednesday | News
Eisai invests ¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan

Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...

April 8, 2023 | Saturday | News
Japanese firm Takeda Pharma inks $415 M deal for celiac disease research

French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...

April 3, 2023 | Monday | News
Japan's NEC establishes European subsidiaries for strengthening global AI drug development biz

Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...

March 31, 2023 | Friday | News
GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases

The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...

March 30, 2023 | Thursday | News
Collaboration in Korea to develop innovative therapeutic antibodies

Genuv Inc., a clinical-stage biotechnology startup focused on drug discovery, and South Korea headquartred Celltrion, a ...

March 17, 2023 | Friday | News
Australia achieves clinical trial success for psoriasis drug

A company launched from Australia-based University of Queensland’s Institute for Molecular Bioscience (I...

March 15, 2023 | Wednesday | News
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome

A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...

March 13, 2023 | Monday | News
Australia to launch revolutionary new cholesterol drug in next two years

Hundreds of thousands of Australians with life-threatening high cholesterol are set to benefit from a revolutionary new ...

March 7, 2023 | Tuesday | News
Japanese firms Teijin and Axcelead establish joint venture for drug discovery research

Japan-based pharmaceutical companies Teijin Limited and Axcelead, Inc. have jointly announced their basic agreemen...

February 23, 2023 | Thursday | News
Australia's Inventia partners with Merck to develop 3D models for neuro disease drug discovery

Australia-based startup Inventia Life Science has partnered with American pharmaceutical firm Merck using Inventia'...

February 17, 2023 | Friday | News
Advances in Oncology Drug Development

Oncology is the growth engine of the pharma industry. The oncology drug market totaled $193 billion in sales in 2021 and...

February 7, 2023 | Tuesday | Opinion
"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"

Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...

January 16, 2023 | Monday | Opinion
Otsuka and Schrödinger announce single-target, drug discovery partnership in neurology

Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...

January 13, 2023 | Friday | News
BioNTech expands by leveraging AI-powered Drug discovery, design and development

BioNTech SE and InstaDeep Ltd. have entered partnership under which BioNTech will acquire InstaDeep to build AI-driven d...

January 11, 2023 | Wednesday | News
Japanese startup Veritas In Silico inks new partnership for mRNA-targeted small molecule drug discovery

Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...

December 30, 2022 | Friday | News
China-based startup XtalPi joins hands with Singapore's national platform for cancer drug discovery

China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...

December 21, 2022 | Wednesday | News
Sosei Heptares & Eli Lilly ink $730 M deal for treatment of diabetes and metabolic diseases

Japan-based Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company, to discover, ...

December 20, 2022 | Tuesday | News
GARDP and Sumitomo Pharma announce partnership in search for new antibiotics

The Global Antibiotic Research and Development Partnership (GARDP) and Japanese firm Sumitomo Pharma Co. have signed an ...

November 24, 2022 | Thursday | News
Chugai extends R&D collaboration in Singapore earmarking S$282M over next 5 years

The Japanese company Chugai Pharmaceutical Co., Ltd., which owns and operates a fully-owned research center "Chugai Phar...

November 16, 2022 | Wednesday | Company results
Ono Pharma inks neuro drug discovery collaboration with Captor Therapeutics

Japan-based Ono Pharmaceutical has entered a worldwide drug discovery collaboration agreement with Poland's Captor The...

November 15, 2022 | Tuesday | News
Korea Drug Development Fund invests in novel oncology candidate

South Korea-based SK Biopharmaceuticals has announced that the state-run Korea Drug Development Fund (KDDF) has decided ...

November 15, 2022 | Tuesday | News